Read this manager's filing book
Disclosed positions
HHLR ADVISORS, LTD.: source evidence dated 2026-08-15T03:59:59.999Z.
- Issuer
- LEGEND BIOTECH CORP
- Ticker
- LEGN
- Class
- SPONSORED ADS
- Reported value
- $172,833,804
- Reported amount
- 5,984,550
- Unit
- SH
- Option
- None
The displayed owner or issuer and source fields identify the receipt to verify; keep reporting and availability dates separate.
What was reported for this quarter?
13F positions are dated quarter-end holdings, with later publication and possible amendments. Read report period and availability before calling them current.
SEC 13F-HR: 0000919574-26-005568Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filings
Open the effective filing receipt and inspect shares, value and any put/call classification separately.
Browse institutional filingsKeep reporting dates and units beside the answer, and inspect its original citations.
Disclosed positions
See the complete disclosed positions
Scroll sideways to compare all columns. Select a heading to sort.
| LEGEND BIOTECH CORP | LEGN | SPONSORED ADS | $172,833,804 | 5,984,550 | SH | None |
| FUTU HLDGS LTD | FUTU | SPON ADS CL A | $165,758,848 | 1,768,283 | SH | None |
| ARRIVENT BIOPHARMA INC | AVBP | COM | $136,497,525 | 3,929,117 | SH | None |
| MARVELL TECHNOLOGY INC | MRVL | COM | $48,536,111 | 162,933 | SH | None |
| VIPSHOP HLDGS LTD | VIPS | SPONSORED ADS A | $46,017,504 | 3,470,400 | SH | None |
| PDD HOLDINGS INC | PDD | SPONSORED ADS | $38,140,000 | 500,000 | SH | None |
| KE HLDGS INC | BEKE | SPONSORED ADS | $32,233,018 | 2,218,377 | SH | None |
| CYTEK BIOSCIENCES INC | CTKB | COM | $29,490,643 | 6,657,030 | SH | None |
| ALAMAR BIOSCIENCES INC | ALMR | COMMON STOCK | $25,910,556 | 956,462 | SH | None |
| ALIBABA GROUP HLDG LTD | BABA | SPONSORED ADS | $17,653,985 | 183,934 | SH | None |
| ODYSSEY THERAPEUTICS INC | ODTX | COMMON STOCK | $15,560,284 | 831,656 | SH | None |
| YATSEN HLDG LTD | YSG | SPONSORED ADS | $15,488,217 | 4,885,873 | SH | None |
| NOVABRIDGE BIOSCIENCES | NBP | SPONSORED ADS | $11,662,108 | 5,980,568 | SH | None |
| CONTINEUM THERAPEUTICS INC | CTNM | CL A | $10,970,433 | 669,337 | SH | None |
| MAZE THERAPEUTICS INC | MAZE | COM | $10,922,276 | 366,028 | SH | None |
| AGORA INC | API | ADS | $8,373,226 | 2,098,553 | SH | None |
| TAIWAN SEMICONDUCTOR MANUFAC | TSM | SPONSORED ADS | $7,407,111 | 15,510 | SH | None |
| SAGIMET BIOSCIENCES INC | SGMT | COM SER A | $5,602,704 | 724,800 | SH | None |
| NETEASE COM INC | NTES | SPONSORED ADS | $4,484,772 | 34,999 | SH | None |
| GE AEROSPACE | GE | COM NEW | $3,753,370 | 10,043 | SH | None |
| LUMENTUM HLDGS INC | LITE | COM | $2,831,598 | 3,300 | SH | None |
| NVIDIA CORPORATION | NVDA | COM | $2,812,065 | 14,054 | SH | None |
| TUYA INC | TUYA | SPONSERED ADS | $2,753,344 | 1,564,400 | SH | None |
| CORNING INC | GLW | COM | $2,622,244 | 10,266 | SH | None |
| COHERENT CORP | COHR | COM | $2,531,314 | 6,417 | SH | None |
| WEBULL CORP | BULL | ORD SHS | $2,020,268 | 309,857 | SH | None |
| INTEL CORP | INTC | COM | $1,996,709 | 14,300 | SH | None |
| PACIFIC BIOSCIENCES CALIF IN | PACB | COM | $1,543,739 | 918,892 | SH | None |
| TEXAS INSTRS INC | TXN | COM | $1,430,736 | 4,800 | SH | None |
| MOGU INC | MOGU | SPON ADS | $1,415,342 | 847,510 | SH | None |
| GOSSAMER BIO INC | GOSS | COM | $818,727 | 4,974,041 | SH | None |
| EQUINOX GOLD CORP | EQX | COM | $782,460 | 80,500 | SH | None |
| ZOOM COMMUNICATIONS INC | ZM | CL A | $777,653 | 9,010 | SH | None |
| ALIGOS THERAPEUTICS INC | ALGS | COM NEW | $439,945 | 76,247 | SH | None |
| RIDGETECH INC | Unresolved | SHS NEW | $204 | 136 | SH | None |
No matching rows. Clear the filter to see all records.
Largest 50 positions by reported value; the filing may contain more positions.
How amendments affect these holdings
This view uses 1 effective filing version(s). A restatement replaces the previous book; a new-holdings amendment adds positions. 1 positions lack a resolved ticker and 0 positions are put or call entries.
A 13F is a delayed quarterly snapshot of disclosed holdings. It is not a complete trade ledger and does not reveal every position in a manager's portfolio. Option values refer to the reported underlying position rather than a traded option premium.
Quarter end and public filing date
Use the filing's public availability date when constructing a historical observation. The quarter-end report period is earlier and cannot be substituted for when the public learned the holdings.